Experience
Experience grounded in real-world decisions
Our founders have contributed to research and applied projects across evidence synthesis, indirect comparisons, survival modelling and HTA. Explore selected examples of our work and scientific contributions.
Publication highlights
87Network meta-analysis & meta-regression
35Population-adjusted indirect comparisons
23Advanced survival & endpoint modelling
15Economic modelling for HTA
Recent conference presentations
| Year | Presentation | Meeting |
|---|---|---|
| 2026 | Which route? Choosing a method for non‑proportional hazards that works for Joint Clinical Assessment and economic models | ISPOR Europe |
| 2025 | What Is Your Estimand? Navigating Conditional and Marginal Effects in Cost-Effectiveness Modeling | ISPOR Europe |
| 2025 | Clinical Trial Design, Beyond the Regulatory | ISPOR |
| 2025 | Large-Language Models to Complement and Augment Literature Review | ISPOR |
| 2024 | Role of Global ITC Programs in Supporting Europe's Joint Clinical Assessments: Insights From Global and EU Experts | ISPOR Europe |
| 2024 | Advanced Methods for Matching-Adjusted Indirect Comparison | ISPOR |
| 2024 | Adjusting Survival Estimates for Treatment Switching: New Guidance and the Role of Real-World Evidence | ISPOR Europe |
| 2024 | Structural Uncertainty in Evidence Synthesis: Model Averaging in Bayesian ML-NMR | ISPOR Europe |
| 2023 | Apples and Oranges in Anchored Indirect Treatment Comparisons – Is There More to It Than Effect Modifiers? | ISPOR |
| 2023 | Alternative Network Meta-Analysis Methods in the Presence of Non-Proportional Hazards | ISPOR |
| 2023 | Indirect Treatment Comparisons of Time-to-Event Outcomes with Mismatched “Time Zero” | ISPOR podium |
Ready to solve your evidence challenge?
Tell us about your evidence question. Based in Canada, working globally.